Stout, Leigh Anne
Kassem, Nawal
Hunter, Cynthia
Philips, Santosh
Radovich, Milan
Schneider, Bryan P.
Article History
Received: 18 February 2021
Accepted: 31 May 2021
First Online: 1 July 2021
Competing interests
: The authors declare the following competing interests: M.R. is an advisor for LifeOmic. M.R. has stock ownership in LifeOmic, Immunomedics, Tyme Technologies. M.R. has contracted research support by Eli Lilly and Boston Biomedical. The remaining authors do not have any competing interests to disclose.